© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
The injectable hormone helps reduce inflammation and fibrosis associated with NAFLD in this population.
According to a study, Egrifta can improve fatty liver disease in people with HIV.
The injectable hormone was approved to treat excess abdominal fat in those with antiretroviral-associated lipodystrophy.
In honor of World AIDS Day, AIDSmeds highlights the year’s top treatment stories.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
